Microwave ablation of lung malignancies with coexisting severe emphysema: a retrospective analysis of safety and efficacy in 26 patients

References

• Rennard SI. COPD: Overview of definitions, epidemiology, and factors influencing its development. Chest. 1998;113(4):235S–241S.
   PubMed Web of Science ®Google Scholar
• Takahashi Y, Matsuda M, Aoki S, et al. Qualitative analysis of preoperative high-resolution computed tomography: risk factors for pulmonary complications after major lung resection. Ann Thorac Surg. 2016;101(3):1068–1074.
   PubMed Web of Science ®Google Scholar
• Zhai R, Yu X, Shafer A, et al. The impact of coexisting COPD on survival of patients with early-stage non-small cell lung cancer undergoing surgical resection. Chest. 2014;145(2):346–353.
   PubMed Web of Science ®Google Scholar
• Kawaguchi T, Sawabata N, Miura S, et al. Prognostic impact of underlying lung disease in pulmonary wedge resection for lung cancer. Int J Clin Oncol. 2019;24(4):366–374.
   PubMed Web of Science ®Google Scholar
• Abtin F, De Baere T, Dupuy DE, et al. Updates on current role and practice of lung ablation. J Thorac Imaging. 2019;34(4):266–277.
   PubMed Web of Science ®Google Scholar
• de Baère T, Palussière J, Aupérin A, et al. Midterm local efficacy and survival after radiofrequency ablation of lung tumors with minimum follow-up of 1 year: prospective evaluation. Radiology. 2006;240(2):587–596.
   PubMed Web of Science ®Google Scholar
• Lencioni R, Crocetti L, Cioni R, et al. Response to radiofrequency ablation of pulmonary tumours: a prospective, intention-to-treat, multicentre clinical trial (the RAPTURE study). Lancet Oncol. 2008;9(7):621–628.
   PubMed Web of Science ®Google Scholar
• Dupuy DE, Fernando HC, Hillman S, et al. Radiofrequency ablation of stage IA non-small cell lung cancer in medically inoperable patients: results from the American College of Surgeons Oncology Group Z4033 (Alliance) trial. Cancer. 2015;121(19):3491–3498.
   PubMed Web of Science ®Google Scholar
• Benson AB, Venook AP, Cederquist L, et al. Colon cancer, version 1.2017, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2017;15(3):370–398.
   PubMed Web of Science ®Google Scholar
• Hess A, Palussière J, Goyers J-F, et al. Pulmonary radiofrequency ablation in patients with a single lung: feasibility, efficacy, and tolerance. Radiology. 2011;258(2):635–642.
   PubMed Web of Science ®Google Scholar
• Sofocleous CT, May B, Petre EN, et al. Pulmonary thermal ablation in patients with prior pneumonectomy. AJR Am J Roentgenol. 2011;196(5):W606–W612.
   PubMed Web of Science ®Google Scholar
• Yang X, Ye X, Zhang L, et al. Microwave ablation for lung cancer patients with a single lung: clinical evaluation of 11 cases. Thorac Cancer. 2018;9(5):548–554.
   PubMed Web of Science ®Google Scholar
• Sidoff L, Dupuy Damian E. Clinical experiences with microwave thermal ablation of lung malignancies. Int J Hyperthermia. 2017;33(1):25–33.
   PubMed Web of Science ®Google Scholar
• Hohberger LA, Schroeder DR, Bartholmai BJ, et al. Correlation of regional emphysema and lung cancer: a lung tissue research consortium-based study. J Thorac Oncol. 2014;9(5):639–645.
   PubMed Web of Science ®Google Scholar
• Grydeland TB, Dirksen A, Coxson HO, et al. Quantitative computed tomography: emphysema and airway wall thickness by sex, age and smoking. Eur Respir J. 2009;34(4):858–865.
   PubMed Web of Science ®Google Scholar
• Orting SN, Petersen J, Thomsen LH, et al. Learning to quantify emphysema extent: what labels do we need? IEEE J Biomed Health Inform. 2020;24(4):1149–1159.
   PubMed Web of Science ®Google Scholar
• National Institute of Health. National Cancer Institute. Common terminology criteria for adverse events (CTCAE version 5) [Internet]. Washington (DC): US Department of Health and Human Services; 2017. Available from: http://evs.nci.nih.gov/ftp1/CTCAE/About.html
   Google Scholar
• Wang D, Li X, Yu W. Intratumoral injection of hypertonic glucose in treating refractory pneumothorax caused by microwave ablation: a preliminary study. Cardiovasc Intervent Radiol. 2019;42(6):915–919.
   PubMed Web of Science ®Google Scholar
• Yong PC, Sigel K, de-Torres JP, et al. The effect of radiographic emphysema in assessing lung cancer risk. Thorax. 2019;74(9):858–864.
   PubMed Web of Science ®Google Scholar
• Zulueta JJ, Wisnivesky JP, Henschke CI, et al. Emphysema scores predict death from COPD and lung cancer. Chest. 2012;141(5):1216–1223.
   PubMed Web of Science ®Google Scholar
• Edwards JG, Duthie DJ, Waller DA. Lobar volume reduction surgery: a method of increasing the lung cancer resection rate in patients with emphysema. Thorax. 2001;56(10):791–795.
   PubMed Web of Science ®Google Scholar
• Venturini M, Cariati M, Marra P, et al. CIRSE standards of practice on thermal ablation of primary and secondary lung tumours. Cardiovasc Intervent Radiol. 2020;43(5):667–683.
   PubMed Web of Science ®Google Scholar
• Palussière J, Chomy F, Savina M, et al. Radiofrequency ablation of stage IA non-small cell lung cancer in patients ineligible for surgery: results of a prospective multicenter phase II trial. J Cardiothorac Surg. 2018;13(1):91.
   PubMed Web of Science ®Google Scholar
• Zheng A, Wang X, Yang X, et al. Major complications after lung microwave ablation: a single-center experience on 204 sessions. Ann Thorac Surg. 2014;98(1):243–248.
   PubMed Web of Science ®Google Scholar
• Kashima M, Yamakado K, Takaki H, et al. Complications after 1000 lung radiofrequency ablation sessions in 420 patients: a single center’s experiences. AJR Am J Roentgenol. 2011;197(4):W576–W580.
   PubMed Web of Science ®Google Scholar
• Vogl TJ, Naguib NNN, Gruber-Rouh T, et al. Microwave ablation therapy: clinical utility in treatment of pulmonary metastases. Radiology. 2011;261(2):643–651.
   PubMed Web of Science ®Google Scholar
• Healey TT, March BT, Baird G, et al. Microwave ablation for lung neoplasms: a retrospective analysis of long-term results. J Vasc Interv Radiol. 2017;28(2):206–211.
   PubMed Web of Science ®Google Scholar
• Belfiore G, Ronza F, Belfiore MP, et al. Patients’ survival in lung malignancies treated by microwave ablation: our experience on 56 patients. Eur J Radiol. 2013;82(1):177–181.
   PubMed Web of Science ®Google Scholar
• Kurilova I, Gonzalez-Aguirre A, Beets-Tan RG, et al. Microwave ablation in the management of colorectal cancer pulmonary metastases. Cardiovasc Intervent Radiol. 2018;41(10):1530–1544.
   PubMed Web of Science ®Google Scholar
• Zheng A, Ye X, Yang X, et al. Local efficacy and survival after microwave ablation of lung tumors: a retrospective study in 183 patients. J Vasc Interv Radiol. 2016;27(12):1806–1814.
   PubMed Web of Science ®Google Scholar
• Wolf FJ, Grand DJ, Machan JT, et al. Microwave ablation of lung malignancies: effectiveness, CT findings, and safety in 50 patients. Radiology. 2008;247(3):871–879.
   PubMed Web of Science ®Google Scholar
• Egashira Y, Singh S, Bandula S, et al. Percutaneous high-energy microwave ablation for the treatment of pulmonary tumors: a retrospective single-center experience. J Vasc Interv Radiol. 2016;27(4):474–479.
   PubMed Web of Science ®Google Scholar